TOP2A and non-small cell lung carcinoma: Importantly, knockdown of TOP2A in osimertinib-resistant EGFRm NSCLC cell lines sensitized their responses to osimertinib, including induction of DNA damage and apoptosis, whereas enforced overexpression of TOP2A in sensitive EGFRm NSCLC cells conferred resistance to osimertinib.